An LC-MS-MS method for the determination of nevirapine, a non-nucleoside reverse transcriptase inhibitor, in human plasma

Journal of Pharmaceutical and Biomedical Analysis

Volumn 31, Issue 5, 2003, Pages 953-959

  Chi, Jingduan ^a,b   Jayewardene, Anura L ^a   Stone, Judith A ^a   Aweeka, Francesca T ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

^b UNIVERSITY OF HOUSTON COLLEGE OF MEDICINE   (United States)

Author keywords

LC MS MS system; Nevirapine; Plasma

Indexed keywords

NEVIRAPINE; PERCHLORIC ACID; PLASMA PROTEIN; RNA DIRECTED DNA POLYMERASE INHIBITOR;

ARTICLE; BLOOD ANALYSIS; CALIBRATION; CENTRIFUGATION; CONTROLLED STUDY; DRUG DETERMINATION; HUMAN; LIQUID CHROMATOGRAPHY; PRECIPITATION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; STANDARD; TANDEM MASS SPECTROMETRY;

EID: 0037384303     PISSN: 07317085     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0731-7085(02)00708-2     Document Type: Article

References (4)

1. Murphy R.L., Montaner J. Expert Opinion on Investigational Drugs. 5:1996;1183-1887.
2. Hollanders R.M.F., Burger D.M. Journal of Chromatography B. 744:2000;65-71.
3. van Heeswijk R.P.G., Hoetelmans R., Beijnen J.H. Journal of Chromatography B. 713:1998;395-399.
4. Pav J.W., Rowland L., Korpalski D.J. Journal of Pharmaceutical and Biomedical Analysis. 20:1999;91-98.